Switch to: References

Add citations

You must login to add citations.
  1. Why Bioethics Needs a Disability Moral Psychology.Joseph A. Stramondo - 2016 - Hastings Center Report 46 (3):22-30.
    The deeply entrenched, sometimes heated conflict between the disability movement and the profession of bioethics is well known and well documented. Critiques of prenatal diagnosis and selective abortion are probably the most salient and most sophisticated of disability studies scholars’ engagements with bioethics, but there are many other topics over which disability activists and scholars have encountered the field of bioethics in an adversarial way, including health care rationing, growth-attenuation interventions, assisted reproduction technology, and physician-assisted suicide. The tension between the (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   18 citations  
  • Why Bioethics Needs a Disability Moral Psychology.Joseph A. Stramondo - 2016 - Hastings Center Report 46 (3):22-30.
    The deeply entrenched, sometimes heated conflict between the disability movement and the profession of bioethics is well known and well documented. Critiques of prenatal diagnosis and selective abortion are probably the most salient and most sophisticated of disability studies scholars’ engagements with bioethics, but there are many other topics over which disability activists and scholars have encountered the field of bioethics in an adversarial way, including health care rationing, growth-attenuation interventions, assisted reproduction technology, and physician-assisted suicide. -/- The tension between (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   15 citations  
  • Ramsey on “Choosing Life” at the End of Life: Conceptual Analysis of Euthanasia and Adjudicating End-of-Life Care Options.Patrick T. Smith - 2018 - Christian Bioethics 24 (2):151-172.
    Ramsey sees life as a gift and a trust given to people by God. This theological understanding of human life frames his judgment of the immorality of euthanasia in its many forms. Assuming Ramsey’s theological insights and framing of this issue, I highlight a particular way of thinking about euthanasia that both seems to capture the essence of the debate and does not necessarily build the moral evaluation into its description. I aim to identify and unpack the description most consistent (...)
    No categories
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   2 citations  
  • Respecting the autonomy of european and american consumers: Defending positive labels on gm foods.Alan Rubel & Robert Streiffer - 2004 - Journal of Agricultural and Environmental Ethics 18 (1):75-84.
    In her recent article, Does autonomy count in favor of labeling genetically modified food?, Kirsten Hansen argues that in Europe, voluntary negative labeling of non-GM foods respects consumer autonomy just as well as mandatory positive labeling of foods with GM content. She also argues that because negative labeling places labeling costs upon those consumers that want to know whether food is GM, negative labeling is better policy than positive labeling. In this paper, we argue that Hansens arguments are mistaken in (...)
    Direct download (5 more)  
     
    Export citation  
     
    Bookmark   6 citations  
  • Local Trans Fat Bans and Consumer Autonomy.Alan Rubel - 2010 - American Journal of Bioethics 10 (3):41-42.
  • Book Review. [REVIEW]Ben A. Rich - 2006 - Theoretical Medicine and Bioethics 27 (6):567-574.
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark  
  • Proxy Consent and Counterfactuals.Yujin Nagasawa - 2008 - Bioethics 22 (1):16-24.
    When patients are in vegetative states and their lives are maintained by medical devices, their surrogates might offer proxy consents on their behalf in order to terminate the use of the devices. The so‐called ‘substituted judgment thesis’ has been adopted by the courts regularly in order to determine the validity of such proxy consents. The thesis purports to evaluate proxy consents by appealing to putative counterfactual truths about what the patients would choose, were they to be competent. The aim of (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   3 citations  
  • Palliative sedation, foregoing life-sustaining treatment, and aid-in-dying: what is the difference?Patrick Daly - 2015 - Theoretical Medicine and Bioethics 36 (3):197-213.
    After a review of terminology, I identify—in addition to Margaret Battin’s list of five primary arguments for and against aid-in-dying—the argument from functional equivalence as another primary argument. I introduce a novel way to approach this argument based on Bernard Lonergan’s generalized empirical method. Then I proceed on the basis of GEM to distinguish palliative sedation, palliative sedation to unconsciousness when prognosis is less than two weeks, and foregoing life-sustaining treatment from aid-in-dying. I conclude that aid-in-dying must be justified on (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   6 citations  
  • Lifespan extension and the doctrine of double effect.Laura Capitaine, Katrien Devolder & Guido Pennings - 2013 - Theoretical Medicine and Bioethics 34 (3):207-226.
    Recent developments in biogerontology—the study of the biology of ageing—suggest that it may eventually be possible to intervene in the human ageing process. This, in turn, offers the prospect of significantly postponing the onset of age-related diseases. The biogerontological project, however, has met with strong resistance, especially by deontologists. They consider the act of intervening in the ageing process impermissible on the grounds that it would (most probably) bring about an extended maximum lifespan—a state of affairs that they deem intrinsically (...)
    Direct download (8 more)  
     
    Export citation  
     
    Bookmark   2 citations  
  • Against the Autonomy Argument for Mandatory GMO Labeling.Jonathan Herington - 2018 - Public Affairs Quarterly 32 (2):85-117.
    Many argue that consumers possess a “right to know” when products contain ingredients derived from genetically modified organisms, on the grounds that it would protect consumer autonomy. In this paper, I critically evaluate that claim. I begin by providing a version of the “consumer autonomy” argument, showing that its success relies on ambiguities in the notion of autonomy. I then distinguish four approaches to autonomy and articulate the circumstances under which they would support active disclosure of a product property. I (...)
    Direct download  
     
    Export citation  
     
    Bookmark